NEXI — Neximmune Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- -$2.41m
Annual cashflow statement for Neximmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.5 | -29.9 | -50.9 | -62.5 | -32.3 |
| Depreciation | |||||
| Non-Cash Items | 1.54 | 2.93 | 3.59 | 6.39 | 4.77 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.842 | -0.089 | 0.655 | 3.93 | -4.88 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -19.4 | -26.4 | -45.8 | -51.2 | -31.4 |
| Capital Expenditures | -1.25 | -0.865 | -2.35 | -1.26 | -0.049 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 10.7 | 1.09 | -51.5 | 51.6 | 0.004 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 9.42 | 0.222 | -53.8 | 50.3 | -0.044 |
| Financing Cash Flow Items | — | -0.364 | -0.019 | 5.15 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 18.8 | 22.1 | 125 | 5.18 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.77 | -4.1 | 25.3 | 4.3 | -31.5 |